Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/14/1998 | US5780647 2,4-Pentadienoic acid derivatives having retinoid-like biological activity |
07/14/1998 | US5780643 Reaction product of aminoethylethanolamine and meadowfoam compound selected from meadowfoam oil, meadowfoam methyl ester and meadowfoam acid; lubricant additive and chemical intermediate to make amphoteric surfactants |
07/14/1998 | US5780642 Imidazole derivatives as therapeutic agents |
07/14/1998 | US5780636 Process for thiopyrans |
07/14/1998 | US5780633 Enzyme inhibitor of testosterone 5-alpha-reductase |
07/14/1998 | US5780632 Imide derivatives and their production and use |
07/14/1998 | US5780620 Reduced sweetness, superior stability, and appropriate viscosity |
07/14/1998 | US5780615 Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom |
07/14/1998 | US5780611 Oligonucleotide which binds with double-stranded promoter region of human collagen gene to form triple helix complex |
07/14/1998 | US5780605 6,9-bridged erythromycin derivatives |
07/14/1998 | US5780604 Bactericides |
07/14/1998 | US5780601 Method for purification of protein "e" from haemophilus influenzae |
07/14/1998 | US5780596 Isolated binding protein used in detection of malignant cell types |
07/14/1998 | US5780592 Transplant, antitumor |
07/14/1998 | US5780516 Material and methods for inhibiting bacterial cell wall biosynthesis |
07/14/1998 | US5780514 Antiprotozoal medicaments |
07/14/1998 | US5780513 Administering aminoguanidine as nitric oxide synthase inhibitor |
07/14/1998 | US5780512 Alkylated (hetero) cyclic compounds |
07/14/1998 | US5780510 2,4-disulfo phenyl butyl nitrone, its salts and their use as pharmaceuticals |
07/14/1998 | US5780508 Pharmacological preparations comprising a cystine derivative |
07/14/1998 | US5780504 Topical alkyl-2-O-L-ascorbyl-phosphates |
07/14/1998 | US5780502 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome |
07/14/1998 | US5780501 Treatment method using anti-neurodegeneratively active 10-aminoaliphatyl-dibenz b,f!oxepines |
07/14/1998 | US5780500 Anti-neurodegeneratively active 10-aminoaliphatyl-dibenzi b,f! oxepines |
07/14/1998 | US5780498 Endothelin receptor antagonists |
07/14/1998 | US5780496 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
07/14/1998 | US5780495 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
07/14/1998 | US5780492 Inhibitors of farnesyl-protein transferase |
07/14/1998 | US5780490 Oxime derivatives, their preparation and their therapeutic use |
07/14/1998 | US5780489 Method for treating amyotrophic lateral sclerosis |
07/14/1998 | US5780487 S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide |
07/14/1998 | US5780486 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation or rheumatoid arthitis |
07/14/1998 | US5780485 Administering adrenergic blocking agent; side effect reduction; fda orange book listed patent for silodosin |
07/14/1998 | US5780484 Promoting repair of neuronal damage caused by disease of injury |
07/14/1998 | US5780483 IL-8 receptor antagonists |
07/14/1998 | US5780482 Condensed 4-aminopyridines with antirheumatic activity |
07/14/1998 | US5780481 Method for inhibiting activation of the human A3 adenosine receptor to treat asthma |
07/14/1998 | US5780479 Use of opioid antagonists to treat impulse-control disorders |
07/14/1998 | US5780477 Trisubstituted phenyl derivatives and processes for their preparation |
07/14/1998 | US5780476 Administering to treat inflammatory disease and rheumatoid arthitis |
07/14/1998 | US5780475 Having reduced side effects |
07/14/1998 | US5780474 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds |
07/14/1998 | US5780473 Substituted biphenyl sulfonamide endothelin antagonists |
07/14/1998 | US5780472 Piperazine derivatives and methods for the preparation thereof and compositions containing the same |
07/14/1998 | US5780471 Tricyclic benzazepine vasopressin antagonists |
07/14/1998 | US5780468 Heterocyclic derivatives, process for their preparation and their therapeutic use |
07/14/1998 | US5780467 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists |
07/14/1998 | US5780464 Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
07/14/1998 | US5780462 Methoxypoly(ethylene glycol) esters of rapamycin |
07/14/1998 | US5780461 Therapeutic treatment of cancer with Protein Kinase C inhibitors |
07/14/1998 | US5780460 Therapeutic methods and delivery systems utilizing sex steroid precursors |
07/14/1998 | US5780458 Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy |
07/14/1998 | US5780457 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
07/14/1998 | US5780456 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
07/14/1998 | US5780455 Nonsettling acidic isotonic aqueous solution comprising sodium citrate, citric acid and sodium chloride |
07/14/1998 | US5780454 Boronic ester and acid compounds |
07/14/1998 | US5780453 Uses of aloe products in the treatment of multiple sclerosis |
07/14/1998 | US5780452 Antimalarial drug |
07/14/1998 | US5780450 Administering topically, parenterally, orally |
07/14/1998 | US5780449 Oligonucelotides; nucleotide sequences |
07/14/1998 | US5780446 Formulations of vesicant drugs and methods of use thereof |
07/14/1998 | US5780445 Tocopheryl glycosides, their preparation, and their use as surfactants, as antioxidants and as the active substance preventing cell ageing in cosmetic or pharmaceutical preparations |
07/14/1998 | US5780443 Sugar retinoids treating skin disorders; side-effect reduction; cosmetics |
07/14/1998 | US5780438 Containing protein hydrolyzates; storage stable |
07/14/1998 | US5780300 Contacting human progenitor cells with agonist of notch function to inhibit differentiation of cells and exposing cells to conditions for proliferation |
07/14/1998 | US5780287 Photoactivated antiviral and antitumor compositions |
07/14/1998 | US5780278 Nucleic acid encoding ?induced by contact with epithelium? (ice) protein of helicobacter pylori; diagnosis of gastrointestinal disorders |
07/14/1998 | US5780274 Culturing, micro and ultrafiltration, concentration, solvent extraction to prodce clavulanic acid, drying, reacting with n,n'-diisopropylethylenediamine producing intermediate, reacting intermediate with potassium 2-ethylhexanoate |
07/14/1998 | US5780265 Kunitz type plasma kallikrein inhibitors |
07/14/1998 | US5780064 Germicidal compositions for the treatment of animal infectious diseases of the hoof |
07/14/1998 | US5780056 Core comprises natural carotenoid and edible oil, wall prepared from gelatin-based material |
07/14/1998 | US5780051 Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
07/14/1998 | US5780050 Drug delivery compositions for improved stability of steroids |
07/14/1998 | US5780049 Enhanced skin penetration system for improved topical delivery of drugs |
07/14/1998 | US5780046 Administering in combination with an acidic component to improve taste |
07/14/1998 | US5780042 Mixture of 2,4-o-furfurylidenesorbitol and/or its alkyl ethers with antioxidants |
07/14/1998 | US5780039 Comprising nonbitter, acidic amine salt of peptide |
07/14/1998 | US5780014 Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
07/14/1998 | US5778886 Vaginal compositions combining a spermicidal agent and a peroxygen compound |
07/14/1998 | CA2223198A1 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
07/14/1998 | CA2158130C Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
07/14/1998 | CA2135752C Use of (e)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of alzheimer's disease |
07/14/1998 | CA2131372C Sugar derivatives of macrolides |
07/14/1998 | CA2126704C Dermatological compositions and methods for the treatment of skin therewith |
07/14/1998 | CA2119192C Pharmaceutical composition having an immunostimulant activity |
07/14/1998 | CA2096970C Anilide derivative |
07/14/1998 | CA2043228C Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions |
07/14/1998 | CA2041113C Thienobenzodiazepine derivatives and their use as pharmaceuticals |
07/14/1998 | CA2026118C Use of a trimethyl-1,3,7 xanthine derivative for the tratment of the memory disturbances and cognitive deficits of aging and alzheimer's disease |
07/14/1998 | CA1339953C 2',5'-phosphorothioate oligoadenylates and antiviral uses thereof |
07/09/1998 | WO1998029548A1 Human mage-like protein |
07/09/1998 | WO1998029432A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
07/09/1998 | WO1998029430A1 G-rich oligo aptamers and methods of modulating an immune response |
07/09/1998 | WO1998029417A1 Cyclic organoselenium compounds, their preparation and their uses |
07/09/1998 | WO1998029415A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
07/09/1998 | WO1998029413A1 3-ARYL SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF1) SPECIFIC LIGANDS |
07/09/1998 | WO1998029411A1 Sulfonamide compounds having 5-ht receptor activity |
07/09/1998 | WO1998029407A2 N-(pyridinylamino)isoindolines for treating alzheimer's and depression |
07/09/1998 | WO1998029405A1 Substituted benzo[1,4]dioxanes as antiobesity agents |
07/09/1998 | WO1998029404A1 Benzopyran derivative originating in propolis |